BIND Therapeutics To Report Fourth Quarter And Year-End 2015 Financial Results On March 15, 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical stage nanomedicine company developing targeted and programmable therapeutics called ACCURINS®, today announced it will host a conference call and live audio webcast on March 15, 2016, at 8:30 a.m. ET to report fourth quarter and year-end 2015 financial results.